AIM News
Staying ahead of Sepsis
LifeBell AI’s founder & CEO, Erez Goren, on his tech start-up's early sepsis prediction solution
LifeBell AI’s founder & CEO, Erez Goren, on his tech start-up's early sepsis prediction solution
AIMed hosted AIMed Intensive Care Unit (ICU) virtual conference yesterday (22 September). Close to 20 field experts presented on topics around data; mach
Leading up to the AIMed ICU (Intensive Care Unit) virtual event taking place on 22 September, AIMed hosted a webinar this July to
In the US, more than 5.7 million adults would be admitted into the intensive care units (ICU) annually. Although a substantial amount of data will be captured from each of them, the granular indications such as the impact of background noises and lighting on patients and aspects that reflect a pe
In 2013, Dr. Tavpritesh Sethi, Physician-scientist and Assistant Professor of Computational Biology at Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) led a study looking at the prevalence of diseases in India. On average, about 200,000 Chronic Obstructive Pulmonary Disease (C
In the latest episode of our AIMed Talks series, Piyush Mathur, an anaesthesiologist and intensivist at the Cleveland Clinic, discusses what inspired him to go into AI as a clinician with no previous computer programming background.
In 2010, the Affordable Care Act (ACA) began financially penalizing hospitals whose 30-day readmission rates for acute myocardial infarction, heart failure,
A prelude to the upcoming AIMed ICU (Intensive Care Unit) virtual event taking place on 22 September, AIMed hosted its latest webinar under the theme:
According to a preprint study funded by Kaiser Permanente, one of the major healthcare providers in the US, about 42% of the patients infected with the novel coronavirus will